434 articles – 313 references  [version française]
Short view
A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition.
Bonaïti B., Alarcon F., Bonadona V., Pennec S., Andrieu N., Stoppa-Lyonnet D., Perdry H., Bonaïti-Pellié C.
Bulletin du Cancer 98, 7 (2011) 779-95 - http://hal.archives-ouvertes.fr/hal-00621051
Life Sciences/Santé publique et épidémiologie
(21708517)
A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition.
Bernard Bonaïti () 1, Flora Alarcon2, 3, Valérie Bonadona4, Sophie Pennec5, Nadine Andrieu6, Dominique Stoppa-Lyonnet7, Hervé Perdry1, Catherine Bonaïti-Pellié1
1:  Troubles du comportement alimentaire de l'adolescent
INSERM : U669 – Université Paris XI - Paris Sud – Université Paris V - Paris Descartes
Maison de Solene 97, Boulevard de Port Royal 75679 PARIS cedex 14
France
2:  Génétique épidémiologique et structures des populations humaines
INSERM : U535 – IFR69 – Université Paris XI - Paris Sud
Hopital Paul Brousse 94817 VILLEJUIF CEDEX
France
3:  MAP5 - Mathématiques appliquées Paris 5
http://www.math-info.univ-paris5.fr/map5/
CNRS : UMR8145 – Université Paris V - Paris Descartes
UFR de Maths et informatique 45 rue des Saints Pères 75270 PARIS CEDEX 06
France
4:  CNRS UMR 5558
Université Claude Bernard - Lyon I
France
5:  INED - Institut National d'Etudes Démographiques Paris
INED
France
6:  Cancer et génôme: Bioinformatique, biostatistiques et épidémiologie d'un système complexe
INSERM : U900 – Institut Curie – MINES ParisTech - École nationale supérieure des mines de Paris
26 rue d'Ulm - 75248 Paris cedex 05
France
7:  Unité de génétique et biologie des cancers
INSERM : U830 – Institut Curie – Université Pierre et Marie Curie [UPMC] - Paris VI
Institut Curie 26, rue d'ulm section de recherche 75248 PARIS CEDEX 05
France
Criteria have been proposed for genetic testing of breast and ovarian cancer susceptibility genes BRCA1 and BRCA2. Using simulations, this study evaluates the efficiency (sensitivity, positive predictive value [PPV] and specificity) of the various criteria used in France. The efficiency of the criteria published in 1998, which are largely used, is not optimal. We show that some extensions of these criteria provide an increase in sensitivity with a low decrease in specificity and PPV. The study shows that scoring systems (Manchester, Eisinger) have similar efficiency that may be improved. In this aim, we propose a new scoring system that takes into account unaffected individuals and kinship coefficients between family members. This system increases sensitivity without affecting PPV and specificity. Finally, we propose a two-step procedure with a large screening by the physician for recommending genetic counselling, followed by a more stringent selection by the geneticist for prescribing genetic testing. This procedure would result in an increase of genetic counselling activity but would allow the identification of almost 80% of mutation carriers among affected individuals, with a mutation detection rate of 15% and a specificity of 88%.
French

Article in peer-reviewed journal
10.1684/bdc.2011.1397
Bulletin du Cancer (Bull Cancer)
Publisher John Libbey Eurotext
ISSN 0007-4551 (eISSN : 1769-6917)
international
2011-07
98
7
779-95

Age Factors – Breast Neoplasms – Family – Female – France – Genes – BRCA1 – BRCA2 – Genetic Predisposition to Disease – Genetic Testing – Guidelines as Topic – Heterozygote Detection – Humans – Ovarian Neoplasms – Sensitivity and Specificity
MAP5 2011-26

Attached file list to this document: 
PDF
nouveau_score_Bul_Cancer.pdf(651.6 KB)